Jacobs Entrusted with Parachute Development Task by NASA

ABM WLDN

Jacobs Engineering Group Inc. has received a $40.3 million task from National Aeronautics and Space Administration’s ("NASA") Johnson Space Center. The new task is part of Jacobs’ JSC Engineering and Technical Services (JETS) contract and is an extension of the existing parachute test/development work being conducted by the company for the Orion Program since 2006.

Jacobs has now been entrusted with executing manned flight prerequisite testing on Orion space capsule’s parachute system. The capsule is being designed to support human deep space exploration. Additionally, Jacobs would produce, deliver and install flight parachutes for the first Orion Exploration Mission (EM-1). The mission involves circumnavigation of the moon and thereafter returning to earth.

The new task has significantly strengthened Jacobs’ status as a premium aerospace technology provider. Since 20017, the company has accomplished 38 full-scale parachute system tests for NASA. In 2014, Jacobs had delivered parachutes for Engineering Flight Test 1 (EFT-1), which were used when Orion reached in a high orbit almost 3,600 miles above earth. Recently, Jacobs successfully completed the seventeenth and concluding engineering development test of the Orion parachute system in Arizona in the U.S Army’s Yuma Proving Grounds.

Share Price and Zacks Rank

Share price of the company stood at $53.09 per share as of Jul 12, 2016. We expect the aforesaid news to result in stock price movement in the near term.

Jacobs currently carries a Zacks Rank #3 (Hold). The company remains on track to boost its financials via new contracts, improved backlogs, greater operational efficiency and increased innovations.

However, headwinds like strong U.S. dollar, intense industry competition and dismal pricing environment in the global mining and energy market raise concerns.

Stocks to Consider

Some better-ranked stocks in the industry include Willdan Group, Inc. (WLDN - Free Report) , ABM Industries Incorporated (ABM - Free Report) and Accretive Health, Inc. . All the three companies currently hold a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>